Neurointerventional Devices Market Size & Share, By Product (Stents, Embolic Coils, Catheter, Wires, Others), Indication (Stroke, Brain Aneurysm, Others), Application (Hospitals, Ambulatory Surgical Center (ASC), Others), Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

التوقعات السوقية:

Neurointerventional Devices Market surpassed USD 2.98 Billion in 2023 and is predicted to exceed USD 5.76 Billion by end of the year 2032, observing around 7.6% CAGR between 2024 and 2032.

• Base Year Value (2023): USD 2.98 Billion
• CAGR (2024-2032): 7.6%
• Forecast Year Value (2032): USD 5.76 Billion
• Historical Data Period: 2019-2023
• Largest Region: North America
• Forecast Period: 2024-2032

سوق الديناميكية:

Growth Drivers & Opportunity:

The increasing prevalence of neurological disorders such as strokes and aneurysms is a major growth driver for the neurointerventional devices market. The rising aging population and growing awareness about minimally invasive procedures are also fueling market growth. Additionally, advancements in technology and the development of innovative neurointerventional devices are creating opportunities for market expansion.

Report Scope

Report Coverage	Details
Segments Covered	Product, Indication, Application
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	Medtronic, Johnson and Johnson Services, Penumbra,, Microport Scientific, Stryker, MicroVention Inc, Codman Neuro

Industry Restraints:

The high costs associated with neurointerventional procedures and devices are a major restraint for market growth. Limited access to healthcare facilities and skilled neurointerventional specialists in developing regions also pose challenges for market development. Overall, these restraints may hinder the growth of the neurointerventional devices market in the coming years.

التوقعات الإقليمية:

The North America neurointerventional devices market is driven by the growing prevalence of neurovascular diseases and increasing demand for minimally invasive procedures in the region. The United States holds the largest market share due to the presence of a well-established healthcare infrastructure and high adoption of advanced neurointerventional devices. Canada, on the other hand, is experiencing steady growth in the market, attributed to the rising awareness about the benefits of neurointerventional procedures among healthcare professionals and patients.

In the Asia Pacific region, countries like China, Japan, and South Korea are witnessing rapid growth in the neurointerventional devices market. China is the largest market in the region, driven by the increasing incidence of stroke and aneurysms, along with a growing geriatric population. Japan is a key market for neurointerventional devices, owing to the high prevalence of neurovascular diseases and the presence of well-established healthcare facilities. South Korea is also experiencing significant market growth due to advancements in technology and increasing investments in healthcare infrastructure.

Europe, specifically the United Kingdom, Germany, and France, is witnessing steady growth in the neurointerventional devices market. The United Kingdom holds a significant market share due to the increasing adoption of minimally invasive procedures and rising healthcare expenditures. Germany is a key market in Europe, driven by the presence of leading neurointerventional device manufacturers and a high demand for innovative treatment options. France is also experiencing market growth, fueled by the rising incidence of neurological disorders and increasing awareness about neurointerventional procedures among patients.

تحليل التجزئة:

In terms of segmentation, the global Neurointerventional Devices market is analyzed on the basis of Product, Indication, Application.

Neurointerventional Devices Market:

Product Analysis:

Stents: The stents segment in the neurointerventional devices market is expected to witness steady growth, driven by the increasing prevalence of strokes and aneurysms.

Embolic Coils: The market for embolic coils is projected to experience significant growth, owing to the rising adoption of minimally invasive procedures for treating brain aneurysms.

Catheter: The catheter segment is anticipated to show promising growth, supported by the growing demand for catheter-based neurointerventional procedures in hospitals and ASCs.

Wires: Wires play a crucial role in neurointerventional procedures, and this segment is likely to witness steady growth due to advancements in technology and an increase in the number of neurosurgeries.

Others: Other neurointerventional devices, such as flow diverters and neurovascular plugs, are expected to contribute positively to the market growth with the rising prevalence of neurological disorders.

Indication Analysis:

Stroke: The indication segment for strokes is anticipated to dominate the neurointerventional devices market, driven by the increasing incidence of strokes worldwide and the growing demand for effective treatment options.

Brain Aneurysm: The brain aneurysm segment is projected to witness substantial growth, supported by advancements in neurointerventional devices and procedures for the treatment of brain aneurysms.

Others: Other indications, such as arteriovenous malformations (AVMs) and tumors, are expected to contribute to the market growth with the rising prevalence of these conditions and the increasing adoption of neurointerventional procedures.

Application Analysis:

Hospitals: Hospitals are expected to be the major end-users of neurointerventional devices, owing to the high patient footfall, availability of skilled healthcare professionals, and advanced infrastructure for performing neurointerventional procedures.

Ambulatory Surgical Center (ASC): The ASC segment is projected to witness significant growth, supported by the increasing preference for outpatient procedures, cost-effectiveness, and convenience offered by ASCs for neurointerventional treatments.

Others: Other end-users, such as neurology clinics and specialty centers, are expected to contribute to the market growth with the rising demand for specialized neurological care and the increasing adoption of neurointerventional devices in these settings.

مشهد تنافسي:

The competitive landscape in the Neurointerventional Devices Market is characterized by a range of innovative companies focused on developing advanced technologies for treating neurological disorders. Key players are investing significantly in research and development to enhance the effectiveness of their devices, resulting in a rapid evolution of treatment options for conditions such as stroke, aneurysms, and vascular malformations. The market sees a mix of established medical device manufacturers and emerging players, with regular product launches and strategic collaborations aimed at capturing market share. Additionally, regulatory pathways and reimbursement policies play a crucial role in shaping competitive dynamics, as industry leaders strive to navigate these complexities while maintaining their product portfolios.

Top Market Players

- Medtronic

- Stryker Corporation

- Boston Scientific Corporation

- Terumo Corporation

- Penumbra Inc.

- NeuroTherapia Inc.

- ASAHI INTECC Co. Ltd.

- MicroVention, Inc.

- Cook Medical

- Johnson & Johnson